A Study of Dalotuzumab (MK-0646) in Breast Cancer Patients (MK-0646-013)
Clinical trial NCT00759785 · COMPLETED
Trial details
- NCT number
- NCT00759785
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-30
- Primary completion
- 2010-02-17
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.